Drugs / PPI-383
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01928147 | Aug 2013 → Jul 2015 | chronic hepatitis C virus infection | Presidio Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPI-383 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01928147 ↗ |
| Action | Inhibit | “an inhibitor of the hepatitis C virus NS5B polymerase” NCT01928147 ↗ |